As part of The Lancet Rheumatology’s special issue on public and patient involvement in rheumatology, in this month’s episode, Aisling talks to Professor Jon Lampa about his recent publication on the patient-reported outcomes from the NORD-STAR trial. The 2023 NORD-STAR trial was the first randomised trial to compare three different biological DMARDs, all i ... Show More
Apr 21
Dirk Foell on trends in paediatric rheumatology care across Europe
In this episode, Professor Dirk Foell from University Hospital Münster unpacks the findings from a recent Europe-wide survey examining trends in paediatric rheumatology care. Despite significant scientific advances, delivering consistent, high-quality care for children with rheum ... Show More
16 m
<p>Host: Darryl S. Chutka. M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Ashima Makol, M.B.B.S.</p>
<p>Guest: Matthew J. Koster, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. I ... Show More
